感染性人工瓣膜心内膜炎再手术:时机趋势与结局
基于英国全国数据库1996–2019年406例因人工瓣膜心内膜炎行再手术的患者,比较早期(≤1年,n=131)与晚期(>1年,n=275)再手术的结局。倾向性评分匹配后,早期再手术组体外循环和主动脉阻断时间更长、住院更久,但死亡率无统计学差异;年龄是死亡的最强预测因素。
要点
- 早期再手术组体外循环和阻断时间更长、住院更久,但死亡率与晚期组无统计学差异
- 年龄是死亡的最强预测因素(OR 1.14,95%CI 1.05–1.27)
- 研究期间再手术总体发生率上升,早期感染性心内膜炎比例从1998年85.7%降至2019年20%
核心结论
- 全国性分析显示人工瓣膜心内膜炎再手术结局较历史数据改善,总体死亡率为8.4%。
- 早期再手术与更复杂的手术和更长住院相关,但死亡率与晚期再手术无统计学差异。
- 年龄仍是死亡风险的主要决定因素。
研究设计与样本
- 基于英国国家心血管结局研究数据库的回顾性队列研究,纳入1996–2019年406例因人工瓣膜心内膜炎行再手术的患者。
- 按再手术时机分为早期组(≤1年,n=131)和晚期组(>1年,n=275),采用倾向性评分匹配比较结局。
- 多变量分析用于识别死亡预测因素。
主要发现
- 研究期间再手术总体发生率上升,早期感染性心内膜炎比例从1998年85.7%降至2019年20%。
- 匹配后(113对),早期再手术组体外循环时间更长(135 vs 122 min,P=0.005),主动脉阻断时间更长(95 vs 88 min,P=0.011),住院时间更长(18.5 vs 14.0天,P=0.006)。
- 总体死亡率为8.4%,早期组死亡率为10.8%,晚期组为6.2%(P=0.338;Lasso AUC:0.746)。
- 年龄是死亡的最强预测因素(OR:1.14,95%CI:1.05–1.27,P=0.0)。
临床怎么用
- 对于人工瓣膜心内膜炎需再手术的患者,应认识到早期再手术手术更复杂、住院更长,但死亡率与晚期再手术无统计学差异。
- 年龄是死亡风险的重要预测因素,在术前风险评估和决策中应予以考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Prosthetic valve endocarditis (PVE) remains a serious complication following aortic valve replacement, with varying outcomes based on timing of presentation. This study investigated the relationship between timing of reoperation and outcomes in PVE patients using a nationwide database, while examining temporal trends and identifying mortality risk factors. METHODS: We analysed 406 patients who underwent reoperative surgery for PVE between 1996 and 2019 across the United Kingdom using the National Institute of Cardiovascular Outcomes Research database. Patients were categorized into early (≤1 year, n = 131) and late (>1 year, n = 275) reoperation groups. Propensity score matching was performed to compare outcomes, and multivariable analysis identified mortality predictors. RESULTS: The overall incidence of reoperative surgery for PVE increased over the study period, while the proportion of early-onset PVE decreased from 85.7% in 1998 to 20% in 2019. In matched groups (113 pairs), early reoperation cases required longer cardiopulmonary bypass (135 vs 122 min, P = 0.005) and cross-clamp times (95 vs 88 min, P = 0.011), with extended hospital stays (18.5 vs 14.0 days, P = 0.006). Overall mortality was 8.4%, with an early mortality of 10.8% opposed to 6.2% in late cases (P = 0.338; Lasso AUC: 0.746). Age emerged as the strongest predictor of mortality (OR: 1.14, 95% CI: 1.05-1.27, P = 0.0). CONCLUSIONS: This nationwide analysis demonstrates improved PVE outcomes compared to historical data, with overall mortality of 8.4%. While early reoperations were associated with more complex procedures and longer hospital stays, mortality rates were statistically similar. Age remains the primary determinant of mortality risk.
引用
- Narayan P, Dong T, Chan J, et al. Reoperative surgery for early- and late-onset prosthetic valve endocarditis: temporal trends and outcomes. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40215181. doi:10.1093/icvts/ivaf096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。